Medizone To Launch AsepticSure In August
Medizone International, Inc. announced that its highly-acclaimed, ozone-based decontamination and infection control technology, AsepticSure™, will be officially launched at one of the world’s premier medical expo events – FIME Miami – on August 10–12, 2011 at the Miami Beach Convention Center.
The buzz in medical science circles around AsepticSure’s potential contribution to global infection control, both in and out of the hospital and broader healthcare environment, is “contagious” to say the least!
Medizone’s CEO, Edwin Marshall, commented, “When you’re sitting on clinically proven hospital beta-tested technology capable of consistently delivering between 6 – 7.9 log?? kill rates against the likes of MRSA, VRE, E.coli, P. Aeruginosa, C.difficile, and B. subtilis, you get a strong sense that attendees at this year’s FIME Show are going to sit up and take note.”
And so they should – because as an ozone vapor-based fumigant, AsepticSure’s demonstrably rapid, high-level disinfection of surfaces and room spaces ‘lends itself’ to a lot more than just the hospital and long-term patient care market. Even the interchangeable modular structure of the AsepticSure™ units has been fashioned to accommodate multiple market applications.
Marshall commented regarding the subject of design aesthetics, “By employing advanced modular design concepts, we’ve been able to develop a production unit that’s seamlessly capable of crossing industries. The exact same unit designed to greatly reduce hospital acquired infections from within the healthcare industry will be perfectly adaptable to the decontamination of the larger spaces found within food processing plants, athletic facilities and clean room manufacturing facilities.”
Each of these examples represents a sizable global industry on its own and should afford Medizone International tremendous commercial opportunity ‘going forward’.
In closing, Marshall stated, “We’re really looking forward to being at FIME in August – and the timing of our own commercial schedule is perfect: AsepticSure’s final product development for production continues on schedule; our patent program continues on schedule; and, based on preliminary interest being shown from various market sectors in the capability of AsepticSure™, the transition to full commercialization later this year is right on target as well.”
Source : Medizone
